AMD is a common eye condition that causes damage to the macula, and is a leading cause of vision loss among people age 50 and older. In some people, AMD advances so slowly that vision loss does not occur for a long time. In others, the disease progresses faster and may lead to a loss of vision in one or both eyes. AMD by itself does not lead to complete blindness, with no ability to see. However, the loss of central vision in AMD can interfere with simple everyday activities, such as the ability to see faces, drive, read, write, or do close work, such as cooking or fixing things around the house.

Optos ultra-widefield (UWF™)  imaging is a revolutionary technology that enables eye care professionals to examine the retina in detail without the need for face-to-face interaction. This novel approach to eye exams enables detailed examinations with no face-to-face interaction and Optos UWF technology may help protect patients and staff by reducing the spread of airborne disease. Image Safely is the fourth pillar of Optos technology and its unrivaled advantage of being non-invasive nature. 

Optos UWF imaging helps doctors find more pathology offering the ONLY single-capture ultra-widefield (UWF™) non-mydriatic images. 97% of doctors using optomap report finding unexpected pathology in the eyes of patients with no visual complaints. An increasing number of doctors have moved to UWF imaging because the field of view allows them to assess virtually the “whole eye”, rather than just the macula, or posterior pole. With optomap, practitioners can quickly and easily acquire a 200-degree FOV of the retina, aiding to protect vision, a pillar of Optos technology. 

optomap ultra-widefield (UWF™) imaging is a proven tool for effective clinical decision making. More than 1,800 clinical trials and hundreds of published case studies and testimonials prove the value of optomap imaging in diagnosis, disease management, and patient engagement, standing as a core pillar of Optos technology.

Optos UWF retinal imaging technology was created to help doctors save sight. More than 20,000 Optos devices are in use worldwide and millions of patients have benefited from optomap^® UWF imaging. A core value of optomap technology and an important pillar on which it stands is the ability to enhance practice and exam flow. optomap UWF technology produces a high-resolution, 200° image in less than ½ second. A proven technology to reduce patient visit time and improve practice flow and practice economics.

Optos ultra-widefield (UWF™) retinal imaging enables healthcare professionals to discover, diagnose, document, and treat ocular pathology that may first present in the periphery - pathology which may go undetected using traditional examination techniques and equipment. Over the next few weeks, we will take a deeper dive into the value of optomap^® technology and the pillars on which it stands; enhance practice flow, improve outcomes, protect vision, and image safely. 

Each year, November 14th is recognized as World Diabetes Day and this year’s theme is “Education to Protect Tomorrow”. Understanding the condition is the first step towards managing and preventing it. One in 10 adults around the world currently live with diabetes, an estimated 537 million people. Almost half do not know they have it.

Optos recently attends the ‘Westminster Eye Health Day’ held on 19 October 2022 as part of the College’s campaign to tackle current and future issues affecting ophthalmology services. The event attendees were offered the opportunity to have their eyes imaged on the Optos Daytona device – the most widely used UWF™ imaging device in the UK.  

Globally, Optos devices with optomap ultra-widefield retinal imaging technology are assisting eye care professionals to offer the most comprehensive eye exams possible. Early detection of any retinal abnormality is crucial to maintaining ocular and systemic health because in most cases of eye disease, in the early stages, they exhibit minimal to no signs or symptoms. Diseases such as macular degeneration, glaucoma, retinal tears or detachments, and other health problems such as diabetes and high blood pressure can be seen with a thorough exam of the retina, which includes the use of optomap. 

Over thirty years ago, a five-year-old boy lost his vision after a regular eye exam failed to spot a retinal detachment. 

His father, Douglas Anderson, made it his mission to revolutionize retinal imaging for eye care professionals. And in 1992 when Optos was founded, his goal was met with the availability of a patient-friendly device that can capture an ultra-widefield (UWF™) high-resolution retinal image. And today, these devices are still the only devices that, in a single-capture, image approximately 82% or 200◦ of the retina.